CAGR

With a top industry award, CodaMetrix validates autonomous AI's power to fix healthcare's costly billing woes, reshaping both finances and jobs.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

Superior Health's acquisition of Pulse Home Health, backed by private equity, signals a major shift in Louisiana's booming home health and hospice market.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

HOTELEX Shanghai 2026 debuts 'The Bar & Drinks Shanghai,' an immersive platform tapping into Asia’s premium beverage and experiential drinking revolution.

Atlanticus Holdings Corp. confirms its quarterly preferred stock dividend, highlighting a rare blend of FinTech innovation with reliable investor returns.

A new business coalition forms to protect NYC's Israeli tech sector, citing hostile policy shifts and rising antisemitism that threaten a vital economic engine.

As AI moves from hype to enterprise reality, data integrity becomes critical. Ataccama's record Q4 growth reveals a new market imperative: data trust.

With a new veteran advisor, SpinLaunch pivots to commercialize its Meridian LEO network, aiming for a 'sovereign' niche in the competitive satellite market.

Private equity giant AEA Investors acquires a majority stake in Magna5, signaling a major push to scale IT services for businesses under cyber siege.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

NextFlex's new podcast, "Electronics at the Edge," explores the flexible, lightweight tech reshaping industries from defense to healthcare.

Powersports giant Massimo Group's stock plummets after announcing a bold but risky plan to acquire an AI firm and enter the health robotics market.

Thoughtworks hires Karthik Srinivasan to scale its AI/works™ platform, betting big on autonomous AI to reshape enterprise software and drive growth.

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

A landmark Medicare decision doubles payment for contrast-enhanced ultrasound, positioning the safer, cheaper alternative to challenge CT and MRI dominance.

Morningstar's $365M CRSP acquisition and extended Vanguard pact positions it to challenge index titans, promising a new era for low-cost investing.

Palomar Holdings finalizes its Gray Surety acquisition, backed by a new $450M credit facility, in a bold strategic move to challenge specialty insurance leaders.